Up regulation of the polycistronic miR-17-92 cluster in CD34+ cells of CML patients was initially described by Venturini et al., 2007 and later was challenged by Agirre et al., 2008 [59,60]. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.